Anticalins: Small engineered binding proteins based on the lipocalin scaffold

Methods in Enzymology

Volumn 503, Issue , 2012, Pages 157-188

  Gebauer, Michaela ^a   Skerra, Arne ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Antibodies; Anticalins; Antigen; E. coli; Keywords; Lipocalins

Indexed keywords

ANTICALIN PROTEIN; BINDING PROTEIN; CELL SURFACE RECEPTOR; COMPLEMENTARY DNA; DNA FRAGMENT; HAPTEN; HORMONE DERIVATIVE; LIPOCALIN; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; SCAFFOLD PROTEIN; UNCLASSIFIED DRUG; VITAMIN D DERIVATIVE;

ARTICLE; BACTERIUM COLONY; BINDING AFFINITY; BIOASSAY; CELL SUSPENSION; CONJUGATION; DRUG DISTRIBUTION; DRUG TARGETING; ELECTROPORATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; EXTRACTION; GENE CASSETTE; GENE FUSION; GENE LIBRARY; HUMAN; IMMUNOGENICITY; MICROTITER PLATE ASSAY; MOLECULAR CLONING; MUTAGENESIS; NONHUMAN; PHAGEMID; PLASMA HALF LIFE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TRANSPORT; SCREENING TEST; SIGNAL TRANSDUCTION; STORAGE; SURFACE PLASMON RESONANCE; TISSUE SPECIFICITY;

ESCHERICHIA COLI;

EID: 84855604118     PISSN: 00766879     EISSN: 15577988     Source Type: Book Series    
DOI: 10.1016/B978-0-12-396962-0.00007-0     Document Type: Chapter

References (49)

1. B. kerström, N. Borregaard, D.A. Flower, and J.-S. Salier Lipocalins 2006 Landes Bioscience Georgetown, TX
2. A. Azimzadeh, J.L. Pellequer, and M.H. Van Regenmortel Operational aspects of antibody affinity constants measured by liquid-phase and solid-phase assays J. Mol. Recognit. 5 1992 9 18
3. B.J. Bachmann Pedigrees of some mutant strains of Escherichia coli K-12 Bacteriol. Rev. 36 1972 525 557
4. G. Beste, F.S. Schmidt, T. Stibora, and A. Skerra Small antibody-like proteins with prescribed ligand specificities derived from the lipocalin fold Proc. Natl. Acad. Sci. USA 96 1999 1898 1903 (Pubitemid 29117839)
5. U. Binder, G. Matschiner, I. Theobald, and A. Skerra High-throughput sorting of an Anticalin library via EspP-mediated functional display on the Escherichia coli cell surface J. Mol. Biol. 400 2010 783 802
6. A.R. Bradbury, S. Sidhu, S. Dübel, and J. McCafferty Beyond natural antibodies: The power of in vitro display technologies Nat. Biotechnol. 29 2011 245 254
7. D.A. Breustedt, I.P. Korndörfer, B. Redl, and A. Skerra The 1.8- crystal structure of human tear lipocalin reveals an extended branched cavity with capacity for multiple ligands J. Biol. Chem. 280 2005 484 493 (Pubitemid 40165013)
8. D.A. Breustedt, D.L. Schönfeld, and A. Skerra Comparative ligand-binding analysis of ten human lipocalins Biochim. Biophys. Acta 1764 2006 161 173
9. D.A. Breustedt, L. Chatwell, and A. Skerra A new crystal form of human tear lipocalin reveals high flexibility in the loop region and induced fit in the ligand cavity Acta Crystallogr. D Biol. Crystallogr. 65 2009 1118 1125
10. W.O. Bullock, J.M. Fernandez, and J.M. Short XL1-Blue: A high efficiency plasmid transforming recA Escherichia coli strain with beta-galactosidase selection Biotechniques 5 1987 376 378
11. I. Couillin, I. Maillet, B.B. Vargaftig, M. Jacobs, G.C. Paesen, P.A. Nuttall, J. Lefort, R. Moser, W. Weston-Davies, and B. Ryffel Arthropod-derived histamine-binding protein prevents murine allergic asthma J. Immunol. 173 2004 3281 3286 (Pubitemid 39142036)
12. N. Ferrara, and R.S. Kerbel Angiogenesis as a therapeutic target Nature 438 2005 967 974 (Pubitemid 43093963)
13. S.P. Fling, and D.S. Gregerson Peptide and protein molecular weight determination by electrophoresis using a high-molarity tris buffer system without urea Anal. Biochem. 155 1986 83 88 (Pubitemid 16034463)
14. D.R. Flower The lipocalin protein family: Structure and function Biochem. J. 318 1996 1 14 (Pubitemid 26283618)
15. M. Gebauer, and A. Skerra Engineered protein scaffolds as next-generation antibody therapeutics Curr. Opin. Chem. Biol. 13 2009 245 255
16. S.C. Gill, and P.H. von Hippel Calculation of protein extinction coefficients from amino acid sequence data Anal. Biochem. 182 1989 319 326 (Pubitemid 19277112)
17. D.H. Goetz, M.A. Holmes, N. Borregaard, M.E. Bluhm, K.N. Raymond, and R.K. Strong The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with siderophore-mediated iron acquisition Mol. Cell 10 2002 1033 1043 (Pubitemid 36001971)
18. K.L. Heckman, and L.R. Pease Gene splicing and mutagenesis by PCR-driven overlap extension Nat. Protoc. 2 2007 924 932 (Pubitemid 46758810)
19. P.N. Hengen Methods and reagents. Preparing ultra-competent Escherichia coli Trends Biochem. Sci. 21 1996 75 76
20. A.M. Hohlbaum, and A. Skerra Anticalins: The lipocalin family as a novel protein scaffold for the development of next-generation immunotherapies Expert Rev. Clin. Immunol. 3 2007 491 501 (Pubitemid 47091227)
21. β autotransporter pathway Gene 178 1996 107 110 (Pubitemid 26377136)
22. R. Karlsson, A. Michaelsson, and L. Mattsson Kinetic analysis of monoclonal antibody-antigen interactions with a new biosensor based analytical system J. Immunol. Methods 145 1991 229 240
23. A.L. Kayushin, M.D. Korosteleva, A.I. Miroshnikov, W. Kosch, D. Zubov, and N. Piel A convenient approach to the synthesis of trinucleotide phosphoramidites - Synthons for the generation of oligonucleotide/peptide libraries Nucleic Acids Res. 24 1996 3748 3755 (Pubitemid 26335384)
24. H.J. Kim, A. Eichinger, and A. Skerra High-affinity recognition of lanthanide(III) chelate complexes by a reprogrammed human lipocalin 2 J. Am. Chem. Soc. 131 2009 3565 3576
25. I.P. Korndörfer, G. Beste, and A. Skerra Crystallographic analysis of an "anticalin" with tailored specificity for fluorescein reveals high structural plasticity of the lipocalin loop region Proteins Struct. Funct. Genet. 53 2003 121 129 (Pubitemid 37059550)
26. I.P. Korndörfer, S. Schlehuber, and A. Skerra Structural mechanism of specific ligand recognition by a lipocalin tailored for the complexation of digoxigenin J. Mol. Biol. 330 2003 385 396 (Pubitemid 36773710)
27. D.G. Myszka Improving biosensor analysis J. Mol. Recognit. 12 1999 279 284 (Pubitemid 129708590)
28. M.A. Nunn, A. Sharma, G.C. Paesen, S. Adamson, O. Lissina, A.C. Willis, and P.A. Nuttall Complement inhibitor of C5 activation from the soft tick Ornithodoros moubata J. Immunol. 174 2005 2084 2091 (Pubitemid 40223951)
29. K.S. Peggs, S.A. Quezada, A.J. Korman, and J.P. Allison Principles and use of anti-CTLA4 antibody in human cancer immunotherapy Curr. Opin. Immunol. 18 2006 206 213 (Pubitemid 43327304)
30. J. Sambrook, E.F. Fritsch, and T. Maniatis Molecular Cloning: A Laboratory Manual 1989 Cold Spring Harbor Laboratory Press Cold Spring Harbor, NY
31. M. Schlapschy, I. Theobald, H. Mack, M. Schottelius, H.J. Wester, and A. Skerra Fusion of a recombinant antibody fragment with a homo-amino-acid polymer: Effects on biophysical properties and prolonged plasma half-life Protein Eng. Des. Sel. 20 2007 273 284 (Pubitemid 47227182)
32. S. Schlehuber, and A. Skerra Tuning ligand affinity, specificity, and folding stability of an engineered lipocalin variant - a so-called 'anticalin' - using a molecular random approach Biophys. Chem. 96 2002 213 228 (Pubitemid 34548234)
33. S. Schlehuber, and A. Skerra Lipocalins in drug discovery: From natural ligand-binding proteins to "anticalins" Drug Discov. Today 10 2005 23 33 (Pubitemid 40164816)
34. S. Schlehuber, G. Beste, and A. Skerra A novel type of receptor protein, based on the lipocalin scaffold, with specificity for digoxigenin J. Mol. Biol. 297 2000 1105 1120
35. T.G. Schmidt, and A. Skerra The Strep-tag system for one-step purification and high-affinity detection or capturing of proteins Nat. Protoc. 2 2007 1528 1535 (Pubitemid 46952331)
36. D. Schönfeld, G. Matschiner, L. Chatwell, S. Trentmann, H. Gille, M. Hülsmeyer, N. Brown, P.M. Kaye, S. Schlehuber, A.M. Hohlbaum, and A. Skerra An engineered lipocalin specific for CTLA-4 reveals a combining site with structural and conformational features similar to antibodies Proc. Natl. Acad. Sci. USA 106 2009 8198 8203
37. A. Skerra Use of the tetracycline promoter for the tightly regulated production of a murine antibody fragment in Escherichia coli Gene 151 1994 131 135
38. A. Skerra Engineered protein scaffolds for molecular recognition J. Mol. Recognit. 13 2000 167 187 (Pubitemid 30613469)
39. A. Skerra Lipocalins as a scaffold Biochim. Biophys. Acta 1482 2000 337 350
40. A. Skerra 'Anticalins': A new class of engineered ligand-binding proteins with antibody-like properties J. Biotechnol. 74 2001 257 275 (Pubitemid 34186236)
41. A. Skerra Imitating the humoral immune response Curr. Opin. Chem. Biol. 7 2003 683 693 (Pubitemid 37486111)
42. A. Skerra Anticalins as alternative binding proteins for therapeutic use Curr. Opin. Mol. Ther. 9 2007 336 344 (Pubitemid 47255666)
43. A. Skerra, M.L. Dreher, and G. Winter Filter screening of antibody Fab fragments secreted from individual bacterial colonies: Specific detection of antigen binding with a two-membrane system Anal. Biochem. 196 1991 151 155
44. F.W. Studier, and B.A. Moffatt Use of bacteriophage T7 RNA polymerase to direct selective high-level expression of cloned genes J. Mol. Biol. 189 1986 113 130
45. W.L. Tung, and K.C. Chow A modified medium for efficient electrotransformation of E. coli Trends Genet. 11 1995 128 129
46. J. Van den Brulle, M. Fischer, T. Langmann, G. Horn, T. Waldmann, S. Arnold, M. Fuhrmann, O. Schatz, T. O'Connell, D. O'Connell, A. Auckenthaler, and H. Schwer A novel solid phase technology for high-throughput gene synthesis Biotechniques 45 2008 340 343
47. M. Venturi, C. Seifert, and C. Hunte High level production of functional antibody Fab fragments in an oxidizing bacterial cytoplasm J. Mol. Biol. 315 2002 1 8 (Pubitemid 34722107)
48. S. Voss, and A. Skerra Mutagenesis of a flexible loop in streptavidin leads to higher affinity for the Strep-tag II peptide and improved performance in recombinant protein purification Protein Eng. 10 1997 975 982 (Pubitemid 27491655)
49. C. Yanisch-Perron, J. Vieira, and J. Messing Improved M13 phage cloning vectors and host strains: Nucleotide sequences of the M13mp18 and pUC19 vectors Gene 33 1985 103 119 (Pubitemid 15122816)